Funding for this research was provided by:
James Augsburger Ocular Oncology Fund (N/A)
Mary Knight Asbury Endowment (N/A)
Dr. E. Vernon and Eloise C. Smith Endowment (N/A)
Text and Data Mining valid from 2018-09-17
Received: 6 June 2018
Accepted: 5 September 2018
First Online: 17 September 2018
Ethics approval and consent to participate
: The Institutional Review Board of the University of Cincinnati has approved an ongoing retrospective review of the Ocular Oncology Database. UC IRB number 2012–4914.
: Written informed consent for publication of clinical details and clinical images was obtained from the parents of the patient. A copy of the consent form is available for review by the Editor of this journal.
: None of the authors has any conflicts of interest pertaining to this case. Dr. Correa is a consultant for Castle Biosciences, Inc.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.